The optimisation of experience sampling protocols in people with schizophrenia

Experience sampling methodology (ESM) involves completing questionnaires during daily life and has been used extensively in people with schizophrenia to assess symptoms and behaviours. Despite considerable advantages over interview measures, there is limited information about its external validity. Our aim is to investigate whether ESM protocol implementation is affected differentially in people with schizophrenia and healthy individuals by factors such as mood, medication and symptoms which would have implications for validity. Fifty-three people with schizophrenia and fifty-eight controls from the general population completed seven ESM questionnaires per day for six consecutive days. Compliance and acceptability, including overall experience, training and disruption of normal routines, were recorded. Overall questionnaire completion rate in people with schizophrenia was comparable to controls (i.e. over 70%). People with schizophrenia completed significantly fewer questionnaires in the morning but did not show fatigue effects over the experience sampling period. Excluding questionnaires in the morning did not significantly alter the findings. In the schizophrenia group medication level and symptoms did not influence adherence. However, higher disruption was associated with reduced questionnaire completion in this group. These findings suggest that minimising disruption may enhance validity and completion rates. ESM is a valid methodology to use with people with schizophrenia.

[1]  C. Depp,et al.  Mobile Interventions for Severe Mental Illness: Design and Preliminary Data From Three Approaches , 2010, The Journal of nervous and mental disease.

[2]  P. Delespaul,et al.  Symptomatic remission in psychosis and real-life functioning , 2012, British Journal of Psychiatry.

[3]  P. Delespaul,et al.  Emotional experience in negative symptoms of schizophrenia--no evidence for a generalized hedonic deficit. , 2013, Schizophrenia bulletin.

[4]  Hongshik Ahn,et al.  Computerized experience sampling method (ESMc): assessing feasibility and validity among individuals with schizophrenia. , 2006, Journal of psychiatric research.

[5]  S. Woods,et al.  Chlorpromazine equivalent doses for the newer atypical antipsychotics. , 2003, The Journal of clinical psychiatry.

[6]  Lewis A. Opler,et al.  Reliability and validity of the positive and negative syndrome scale for schizophrenics , 1988, Psychiatry Research.

[7]  I. Myin-Germeys,et al.  Mobile assessment guide for research in schizophrenia and severe mental disorders. , 2012, Schizophrenia bulletin.

[8]  T. Wykes,et al.  The Feasibility and Acceptability to Service Users of CIRCuiTS, a Computerized Cognitive Remediation Therapy Programme for Schizophrenia , 2015, Behavioural and cognitive psychotherapy.

[9]  J. Ainsworth,et al.  The feasibility and validity of ambulatory self-report of psychotic symptoms using a smartphone software application , 2012, BMC Psychiatry.

[10]  Teresa Paiva,et al.  Sleep–wake patterns in schizophrenia patients compared to healthy controls , 2014, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[11]  Tx Station Stata Statistical Software: Release 7. , 2001 .

[12]  Y. Liu,et al.  Use of mobile assessment technologies in inpatient psychiatric settings. , 2014, Asian journal of psychiatry.

[13]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[14]  T. Lataster,et al.  Mobile assessment in schizophrenia: a data-driven momentary approach. , 2012, Schizophrenia bulletin.

[15]  J. Bobes,et al.  Treatment adherence and quality of sleep in schizophrenia outpatients , 2014, International journal of psychiatry in clinical practice.

[16]  J. Kane Improving patient outcomes in schizophrenia: achieving remission, preventing relapse, and measuring success. , 2013, The Journal of clinical psychiatry.

[17]  D. R. Weinberger,et al.  Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia , 2012, Schizophrenia Research.

[18]  T. Wykes,et al.  VOICE: Developing a new measure of service users’ perceptions of inpatient care, using a participatory methodology , 2012, Journal of mental health.

[19]  T. Wykes,et al.  It is all in the factors: Effects of cognitive remediation on symptom dimensions , 2014, Schizophrenia Research.

[20]  R. Bentall,et al.  Emotions, self-esteem, and paranoid episodes: an experience sampling study. , 2011, The British journal of clinical psychology.